# Nuclide record nct06474806 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct06474806/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct06474806", "NCT06474806" ;
  schema:name "Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer"@en ;
  schema:alternateName "uTRACE-101"@en ;
  schema:description "A phase 2 trial of 64Cu-DOTA-AE105 in prostate cancer, run by Curasight, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct06474806/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06474806> ;
  nuclide:status "recruiting" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:phase "2" ;
  nuclide:related <https://nuclide.cc/isotopes/cu-64/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet/> .